{"id":"https://genegraph.clinicalgenome.org/r/60e3739a-3d7c-4e5d-875a-691752a395ffv1.0","type":"EvidenceStrengthAssertion","dc:description":"KIF21A was first reported in relation to autosomal dominant congenital fibrosis of the extraocular muscles (CFEOM) in 2003 (Yamada et al., PMID:14595441). CFEOM is a syndrome of congenital nonprogressive bilateral ophthalmoplegia affecting the extraocular muscles innervated by the oculomotor and/or trochlear nerves. Classic presentations of CFEOM are characterized by ptosis, severe limitation of vertical gaze, and inability to raise either eye above the midline with variable limitation of the horizontal gaze. This disorder has historically been referred to as both CFEOM1 and CFEOM3, the latter characterized by a milder, sometimes unilateral presentation.Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern, and phenotypic variability. Therefore, the following disease entities have been lumped into one disease entity, CFEOM1 (OMIM:135700) and CFEOM3 (OMIM:135700). Evidence supporting this gene-disease relationship includes case-level, segregation, and experimental data. Eleven missense variants reported across 33 probands in seven publications (PMIDs: 14595441,15621877, 15621876, 18332320, 15223798, 19551685, 17511870) are included in this curation. Of the variants reported in this curation, all were absent from gnomAD and the most frequent variant (R954W) was reported in 21 probands, 9 of which were de novo observations. This specific variant is the most common for this syndrome, and variants at this residue (R954) account for the majority of cases. This residue has been shown to contain a CpG dinucleotide that is methylated, providing some insight into the high mutability of this region in KIF21A (PMID:15621877). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be gain of function. This gene-disease relationship is also supported by animal models and expression studies (PMIDs:24656932, 22465342). Knock-in mice containing the R954W variant have been shown to exhibit CFEOM phenotypes with minimal differences, and KIF21A has been shown to be expressed normally in human and murine extraocular and skeletal muscle cells. In summary, KIF21A is definitively associated with autosomal dominant CFEOM. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Brain Malformations Expert Panel on the meeting date 09/28/21 (SOP Version 8). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/60e3739a-3d7c-4e5d-875a-691752a395ff","GCISnapshot":"https://genegraph.clinicalgenome.org/r/cc32bbc2-de76-42d0-8a6b-b3c3393ddd30","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/cc32bbc2-de76-42d0-8a6b-b3c3393ddd30_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2021-10-26T14:48:54.679Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/cc32bbc2-de76-42d0-8a6b-b3c3393ddd30_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2021-10-26T14:49:09.400Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc32bbc2-de76-42d0-8a6b-b3c3393ddd30_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7915a276-776f-4d35-8ba6-ebb17dd3916f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7915a276-776f-4d35-8ba6-ebb17dd3916f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14595441","allele":{"id":"https://genegraph.clinicalgenome.org/r/38987638-3349-44ea-90be-5ed7cc69a8da","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001173464.2(KIF21A):c.2861G>A (p.Arg954Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115555"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/74cb0afb-41c3-4c67-bfe6-062b6bc5767a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74cb0afb-41c3-4c67-bfe6-062b6bc5767a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19551685","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001173464.2(KIF21A):c.2860C>T (p.Arg954Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115554"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b194f30d-e6dd-4e65-849a-08ced71f684e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b194f30d-e6dd-4e65-849a-08ced71f684e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15223798","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5026c90-69d2-42e7-89b8-7f3fb5057bf5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001173464.2(KIF21A):c.2841G>A (p.Met947Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115556"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ddbe7aee-c0a6-4288-bf84-9023caf4f45e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ddbe7aee-c0a6-4288-bf84-9023caf4f45e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14595441","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1779a9d-ec97-4df4-85d6-1a8e08ea20e1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001173464.2(KIF21A):c.2839A>G (p.Met947Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252284"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/089a3e73-2a20-4ec9-b20d-9f50ca1a8188","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/089a3e73-2a20-4ec9-b20d-9f50ca1a8188_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14595441","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/78e747eb-1106-4dc3-a0ee-7290063b9a80","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78e747eb-1106-4dc3-a0ee-7290063b9a80_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621876","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4ffd2f8f-ed25-406e-ada2-b962fc569d00","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ffd2f8f-ed25-406e-ada2-b962fc569d00_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Analysis of dinucleotide CpG methylation was done via bisulfate genomic sequencing which revealed that the PCR amplified product had C residues occurring in the three CpG dinucleotides remained C residues, indicating methylation. This provides a molecular basis for the high rate of mutations at this position. ","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/4ffd2f8f-ed25-406e-ada2-b962fc569d00_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621877","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b790c148-a99f-45de-8b88-5d9849c167dc","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b790c148-a99f-45de-8b88-5d9849c167dc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19551685","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/92163c30-ff77-461f-94f8-1a1376c5654a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92163c30-ff77-461f-94f8-1a1376c5654a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14595441","allele":{"id":"https://genegraph.clinicalgenome.org/r/c3949ed1-0588-4f7c-9c9d-f17884a976ec","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001173464.2(KIF21A):c.1067T>C (p.Met356Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339982"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/22954ab4-58ab-4e71-9bd7-fba0e5897fac","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/22954ab4-58ab-4e71-9bd7-fba0e5897fac_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14595441","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/54b81bcf-e699-4e53-a816-08a8125d8076","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54b81bcf-e699-4e53-a816-08a8125d8076_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14595441","allele":{"id":"https://genegraph.clinicalgenome.org/r/b7072f52-f3f0-4abc-9082-a621e00dcad1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001173464.2(KIF21A):c.3029T>C (p.Ile1010Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252283"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/04bb773f-0332-42ae-ac67-1f1f29dd1479","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04bb773f-0332-42ae-ac67-1f1f29dd1479_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621876","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/257c1df6-7b28-48b1-886f-241009b218c9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/257c1df6-7b28-48b1-886f-241009b218c9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17511870","allele":{"id":"https://genegraph.clinicalgenome.org/r/4fd5bafa-5e99-4371-8a53-c0adfb6c441e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001173464.2(KIF21A):c.2861G>T (p.Arg954Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384393097"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/030e9812-7e5a-43f2-9c79-bd15a52abd9a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/030e9812-7e5a-43f2-9c79-bd15a52abd9a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14595441","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8c89f6e2-72e3-4c0d-bcc9-6a04ebab453b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c89f6e2-72e3-4c0d-bcc9-6a04ebab453b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19551685","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e81f76f3-a4a9-4000-8077-d62b059461f4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e81f76f3-a4a9-4000-8077-d62b059461f4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14595441","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2508f486-871b-4918-863c-028e3d85c3ad","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2508f486-871b-4918-863c-028e3d85c3ad_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18332320","allele":{"id":"https://genegraph.clinicalgenome.org/r/51c0bb8f-7d83-4c74-9336-e331ba786f2a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001173464.2(KIF21A):c.84C>G (p.Cys28Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347964"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c5f6318c-48bd-4aff-a340-c9b087b83f18","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5f6318c-48bd-4aff-a340-c9b087b83f18_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19551685","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/59fb4186-133c-4ae0-b17b-76c3700af56b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59fb4186-133c-4ae0-b17b-76c3700af56b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19551685","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/042ab391-13b3-43f5-bff3-0c8f86bc728a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/042ab391-13b3-43f5-bff3-0c8f86bc728a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621876","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/aed84e52-65b6-4301-b6c6-439f9defd3c9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aed84e52-65b6-4301-b6c6-439f9defd3c9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14595441","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8a80c757-4625-4f5c-92df-a666f3a1deb9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a80c757-4625-4f5c-92df-a666f3a1deb9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14595441","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8dd77387-c38f-48c5-b3e7-bbb4da9282ad","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8dd77387-c38f-48c5-b3e7-bbb4da9282ad_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18332320","allele":{"id":"https://genegraph.clinicalgenome.org/r/38987638-3349-44ea-90be-5ed7cc69a8da"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/73f7464e-59ca-4d49-821a-a80362fb532e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73f7464e-59ca-4d49-821a-a80362fb532e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17511870","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/70f0d841-0b24-41f9-bf9b-71089fb5e443","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/70f0d841-0b24-41f9-bf9b-71089fb5e443_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14595441","allele":{"id":"https://genegraph.clinicalgenome.org/r/0535a335-5c79-461d-aadc-d2cfa23deee8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001173464.2(KIF21A):c.2840T>G (p.Met947Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252285"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/720c18b2-e602-4cab-a6f8-b83a338e174d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/720c18b2-e602-4cab-a6f8-b83a338e174d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17511870","allele":{"id":"https://genegraph.clinicalgenome.org/r/ae3e1dfe-8fd2-4c14-9c89-dc111a2a3dc4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001173464.2(KIF21A):c.3022G>C (p.Ala1008Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384392609"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a01580f1-0192-4d60-9dbc-559275c47e2c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a01580f1-0192-4d60-9dbc-559275c47e2c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14595441","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/db760146-9547-4795-ab9b-d6a414923090","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db760146-9547-4795-ab9b-d6a414923090_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18332320","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/094c2206-363f-4427-a56e-e76092d254a8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/094c2206-363f-4427-a56e-e76092d254a8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14595441","allele":{"id":"https://genegraph.clinicalgenome.org/r/38987638-3349-44ea-90be-5ed7cc69a8da"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f8b310fc-f85a-4ed2-a185-e9ec876ebc3c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8b310fc-f85a-4ed2-a185-e9ec876ebc3c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621876","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/cc32bbc2-de76-42d0-8a6b-b3c3393ddd30_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/520d7346-2c51-469b-82cf-1c3b1c184de3_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621876","rdfs:label":"Family I ","family":{"id":"https://genegraph.clinicalgenome.org/r/520d7346-2c51-469b-82cf-1c3b1c184de3","type":"Family","rdfs:label":"Family I ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/489fe812-6516-451a-8ea5-fda092050246","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621876","rdfs:label":"Proband 4","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"detectionMethod":"PCR was used to amplify the 38 KIF21A exons and flanking intronic sequence from genomic PCR amplification of DNA obtained from blood samples was used to analyze exons 20 and 21 in the KIF21A gene. DNA typing for linkage to the FEOM1 (12p11.2-q12) loci was performed on lymphocyte DNA using the polymorphic fluorescent microsatellite markers D12S1048 and D12S331.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Bilateral ptosis and infraducted eyes ","phenotypes":["obo:HP_0001491","obo:HP_0001488"],"previousTesting":false,"secondTestingMethod":"Linkage analysis","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f8b310fc-f85a-4ed2-a185-e9ec876ebc3c_variant_evidence_item"}}},"phenotypeFreeText":"Bilateral ptosis and infraducted eyes ","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0001491","obo:HP_0001488"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/489fe812-6516-451a-8ea5-fda092050246"}},{"id":"https://genegraph.clinicalgenome.org/r/1d4c2809-c0fa-44ff-95bd-8cf36b99c2d1_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15223798","rdfs:label":"BE","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/1d4c2809-c0fa-44ff-95bd-8cf36b99c2d1","type":"Family","rdfs:label":"BE","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/54597745-672f-49cd-8441-5c1860409191","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15223798","rdfs:label":"II:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"detectionMethod":"High molecular weight DNA extracted from blood samples and used for PCR amplification of the 38 coding exons of KIF21A and the flanking intron-exon boundaries. Linkage analysis using fluorescent markers spanning the FEOM1, FEOM2, and FEOM3 loci. \n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Slight residual upgaze","phenotypes":"obo:HP_0001491","previousTesting":false,"secondTestingMethod":"Linkage analysis","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b8c58efb-9d6e-4b98-b2e4-64dc3be68d71_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15223798","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Slight residual upgaze","phenotypePositiveAllelePositive":6,"phenotypes":"obo:HP_0001491","proband":{"id":"https://genegraph.clinicalgenome.org/r/54597745-672f-49cd-8441-5c1860409191"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/45628dbb-c1cc-44ea-a4eb-f968027b76d5_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621877","rdfs:label":" Family IISC-1","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/45628dbb-c1cc-44ea-a4eb-f968027b76d5","type":"Family","rdfs:label":" Family IISC-1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/0a5e2031-68cf-4e3e-a216-687e2a615392","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621877","rdfs:label":"III-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"detectionMethod":"Mutational analysis of exons 8, 20, and 21.\n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Congenital, non-progressive bilateral ptosis and external ophthalmoplegia with the eyes fixed in a strabismic and hypotropic position. No other abnormalities were noticed. \nand their intelligence and development appeared to be normal","phenotypes":["obo:HP_0000006","obo:HP_0001491","obo:HP_0007936","obo:HP_0001488"],"previousTesting":true,"previousTestingDescription":"Peripheral blood for DNA extraction was collected from 9 family members of the CFEOM family IISC1. Linkage analysis was performed using the program SIMLINK to determine the maximum potential lod score possible assuming a tetra-allelic marker with a heterozygosity = 0.75 and performing 10,000 replicates. Lod scores (Z) were calculated using VITESSE.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4ffd2f8f-ed25-406e-ada2-b962fc569d00_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"All affected individual presented the classic form of CFEOM: congenital,\nnon-progressive bilateral ptosis and external ophthalmoplegia with the eyes fixed in a strabismic and hypotropic position. No other abnormalities were noticed. \nand their intelligence and development appeared to be normal","phenotypePositiveAllelePositive":8,"phenotypes":["obo:HP_0007936","obo:HP_0001488","obo:HP_0001491","obo:HP_0000006"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0a5e2031-68cf-4e3e-a216-687e2a615392"},"publishedLodScore":2.02,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e6907ba3-8862-45c8-b4e2-eec5ade1144a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19551685","rdfs:label":"Family 1","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/e6907ba3-8862-45c8-b4e2-eec5ade1144a","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/0731b3ec-fe4c-4483-9b75-c7c4a7567913","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19551685","rdfs:label":"I:2","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"detectionMethod":"DNA extracted form blood samples were used for genetic analysis via PCR. All 37 KIF21A exons  and corresponding exon-intron boundaries were amplified from genomic DNA. Haplotype analysis was also used to to genotype for genetic markers flanking the KIF21A gene. \n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Eyes fixed in downgaze and exotropia or esotropia and severe limitation of elevation.\nBilateral ptosis was present in all individuals in a variable degree. ","phenotypes":["obo:HP_0001488","obo:HP_0000577","obo:HP_0000006","obo:HP_0001491"],"previousTesting":false,"secondTestingMethod":"Other","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/c5f6318c-48bd-4aff-a340-c9b087b83f18_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Eyes fixed in downgaze and exotropia or esotropia and severe limitation of elevation. Bilateral ptosis was present in all individuals to a variable degree. ","phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0001491","obo:HP_0000006","obo:HP_0001488","obo:HP_0000577"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0731b3ec-fe4c-4483-9b75-c7c4a7567913"}},{"id":"https://genegraph.clinicalgenome.org/r/81ab55ca-f2e6-4e03-995c-6983d6375887_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15223798","rdfs:label":"BW","estimatedLodScore":9.03,"family":{"id":"https://genegraph.clinicalgenome.org/r/81ab55ca-f2e6-4e03-995c-6983d6375887","type":"Family","rdfs:label":"BW","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/6b9f1777-43c9-4165-b81f-2ee102d83035","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15223798","rdfs:label":"III:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5026c90-69d2-42e7-89b8-7f3fb5057bf5"},"detectionMethod":"High molecular weight DNA was extracted from blood samples and used for PCR amplification of the 38 coding exons of KIF21A and the flanking intron-exon boundaries. Analysis using DHPLC\nLinkage analysis using fluorescent markers spanning the FEOM1, FEOM2, and FEOM3 loci.\n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Absent unilateral ptosis, orthotropic primary position, and elevation of the eyes above midline. ","phenotypes":["obo:HP_0007936","obo:HP_0001491","obo:HP_0001488","obo:HP_0000006"],"previousTesting":true,"previousTestingDescription":"PCR was performed of lymphocyte DNA obtained from blood samples from all participating family members. Linkage studies were conducted\nusing polymorphic DNA microsatellite markers from the CFEOM1,1,2 CFEOM2,3 and CFEOM34 regions. ","secondTestingMethod":"Linkage analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b194f30d-e6dd-4e65-849a-08ced71f684e_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Absent unilateral ptosis, orthotropic primary position, and elevation of the eyes above midline. ","phenotypePositiveAllelePositive":31,"phenotypes":["obo:HP_0001488","obo:HP_0007936","obo:HP_0001491","obo:HP_0000006"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/6b9f1777-43c9-4165-b81f-2ee102d83035"},"publishedLodScore":10.8,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/a632dada-8656-4f6a-82eb-df24f37a9a82_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18332320","rdfs:label":"Family 5","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/a632dada-8656-4f6a-82eb-df24f37a9a82","type":"Family","rdfs:label":"Family 5","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/942463a9-dc80-4c9a-bb55-3afc90e6d530","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18332320","rdfs:label":"IV: 2","allele":{"id":"https://genegraph.clinicalgenome.org/r/51c0bb8f-7d83-4c74-9336-e331ba786f2a"},"detectionMethod":"The 38 exons and flanking exon-intron boundaries of the KIF21A gene were sequenced via PCR. Exons 8, 20, and 21, with reported mutations were sequenced in the proband. \nLinkage analysis was used to genotype the FEOM1 locus using markers D12S1648, D12S59, D12S1029, and D12S1048, and the FEOM3 locus using markers D16S486, D16S498, D16S689, D16S3121, and D16S303. \n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Bilateral severe ptosis, compensatory head position with typical chin-up appearance, hypotropia with or without exotropia, and severely impaired vertical and horizontal ocular motility\n","phenotypes":["obo:HP_0001477","obo:HP_0001488","obo:HP_0001491"],"previousTesting":false,"secondTestingMethod":"Linkage analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2508f486-871b-4918-863c-028e3d85c3ad_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Bilateral severe ptosis, compensatory head position with typical chin-up appearance, hypotropia with or without exotropia, and severely impaired vertical and horizontal ocular motility\n","phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0001491","obo:HP_0001488","obo:HP_0001477"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/942463a9-dc80-4c9a-bb55-3afc90e6d530"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/2aa61d42-4913-497f-bb34-ceefd878188a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18332320","rdfs:label":"Family 3","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/2aa61d42-4913-497f-bb34-ceefd878188a","type":"Family","rdfs:label":"Family 3","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/51c888ff-0692-4da2-a156-618bc2ad2f45","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18332320","rdfs:label":"III:1 ","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"detectionMethod":"The 38 exons and flanking exon-intron boundaries of the KIF21A gene were sequenced via PCR. Exons 8, 20, and 21, with reported mutations were sequenced in the proband. \n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Bilateral severe ptosis, compensatory head position with typical chin-up appearance, hypotropia with or without exotropia, and severely impaired vertical and horizontal\nocular motility\n","phenotypes":["obo:HP_0001491","obo:HP_0001488","obo:HP_0001477"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/db760146-9547-4795-ab9b-d6a414923090_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Bilateral severe ptosis, compensatory head position with typical chin-up appearance, hypotropia with or without exotropia, and severely impaired vertical and horizontal\nocular motility\n","phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0001477","obo:HP_0001488","obo:HP_0001491"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/51c888ff-0692-4da2-a156-618bc2ad2f45"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/98048b13-3211-493f-b897-9d1db8ef4a03_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18332320","rdfs:label":"Family 1","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/98048b13-3211-493f-b897-9d1db8ef4a03","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/d7cd1c39-e3ad-4a2c-a10d-71bb1f7736b2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18332320","rdfs:label":"III:2","allele":{"id":"https://genegraph.clinicalgenome.org/r/38987638-3349-44ea-90be-5ed7cc69a8da"},"detectionMethod":"The 38 exons and flanking exon-intron boundaries of the KIF21A gene were sequenced via PCR. Exons 8, 20, and 21, with reported mutations were sequenced in the proband ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Bilateral severe ptosis, compensatory head position with typical chin-up appearance, hypotropia with or without exotropia, and severely impaired vertical and horizontal\nocular motility\n","phenotypes":["obo:HP_0001488","obo:HP_0001477","obo:HP_0000006","obo:HP_0007936","obo:HP_0001491"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8dd77387-c38f-48c5-b3e7-bbb4da9282ad_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Bilateral severe ptosis, compensatory head position with typical chin-up appearance, hypotropia with or without exotropia, and severely impaired vertical and horizontal\nocular motility\n","phenotypePositiveAllelePositive":8,"phenotypes":["obo:HP_0001477","obo:HP_0000006","obo:HP_0001488","obo:HP_0001491","obo:HP_0007936"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/d7cd1c39-e3ad-4a2c-a10d-71bb1f7736b2"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/a42efa20-85c2-4a75-a3c8-7a5799154ade_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19551685","rdfs:label":"Family 2","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/a42efa20-85c2-4a75-a3c8-7a5799154ade","type":"Family","rdfs:label":"Family 2","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/073ad0b8-81a3-4119-a251-de1f9772b43b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19551685","rdfs:label":"III:8","ageType":"AgeAtReport","ageUnit":"Years","ageValue":44,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"detectionMethod":"DNA extracted form blood samples were used for genetic analysis via PCR. All 37 KIF21A exons  and corresponding exon-intron boundaries were amplified from genomic DNA. Haplotype analysis was also used to to genotype for genetic markers flanking the KIF21A gene. \n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Eyes fixed in downgaze and exotropia or esotropia and severe limitation of elevation. Bilateral ptosis was present in all individuals in a variable degree. ","phenotypes":["obo:HP_0000577","obo:HP_0001491","obo:HP_0001488","obo:HP_0000006"],"previousTesting":false,"secondTestingMethod":"Other","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b790c148-a99f-45de-8b88-5d9849c167dc_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Eyes fixed in downgaze and exotropia or esotropia and severe limitation of elevation. Bilateral ptosis was present in all individuals to a variable degree. ","phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0000577","obo:HP_0000006","obo:HP_0001488","obo:HP_0001491"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/073ad0b8-81a3-4119-a251-de1f9772b43b"}},{"id":"https://genegraph.clinicalgenome.org/r/791f7f7e-140e-424b-acf4-8da654b2f5bc_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621876","rdfs:label":"Family T","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/791f7f7e-140e-424b-acf4-8da654b2f5bc","type":"Family","rdfs:label":"Family T","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/0cc1729a-973c-4cf5-afe2-8f5354ae6706","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621876","rdfs:label":"Proband 1 ","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"detectionMethod":"PCR amplification of DNA obtained from blood samples was used to analyze exons 20 and 21 in the KIF21A gene.  DNA typing for linkage to the FEOM1 (12p11.2-q12) loci was performed on lymphocyte DNA using the polymorphic fluorescent microsatellite markers D12S1048 and D12S331.\n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Bilateral ptosis and infraducted eyes ","phenotypes":["obo:HP_0001488","obo:HP_0001491"],"previousTesting":true,"previousTestingDescription":"PCR was used to  amplify the 38 KIF21A exons and flanking intronic sequence from genomic DNA. Thirty-one exons were screened by DHPLC. These PCR products were used directly for DHPLC and, if wave abnormalities were detected, were then purified and used as templates for direct sequencing. ","secondTestingMethod":"Linkage analysis","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/78e747eb-1106-4dc3-a0ee-7290063b9a80_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Bilateral ptosis and infraducted eyes ","phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0001491","obo:HP_0001488"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0cc1729a-973c-4cf5-afe2-8f5354ae6706"}},{"id":"https://genegraph.clinicalgenome.org/r/2cd95150-b850-4b2d-bf95-16db19696d12_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621876","rdfs:label":"Family F","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/2cd95150-b850-4b2d-bf95-16db19696d12","type":"Family","rdfs:label":"Family F","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/84ea34e7-1247-4eca-aa27-377a2de850c7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621876","rdfs:label":"Proband 2","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"detectionMethod":"PCR was used to amplify the 38 KIF21A exons and flanking intronic sequence from genomic PCR amplification of DNA obtained from blood samples was used to analyze exons 20 and 21 in the KIF21A gene. DNA typing for linkage to the FEOM1 (12p11.2-q12) loci was performed on lymphocyte DNA using the polymorphic fluorescent microsatellite markers D12S1048 and D12S331.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Bilateral ptosis and infraducted eyes ","phenotypes":["obo:HP_0001491","obo:HP_0001488"],"previousTesting":false,"secondTestingMethod":"Linkage analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/042ab391-13b3-43f5-bff3-0c8f86bc728a_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Bilateral ptosis and infraducted eyes ","phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001491","obo:HP_0001488"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/84ea34e7-1247-4eca-aa27-377a2de850c7"}},{"id":"https://genegraph.clinicalgenome.org/r/8c3a3be8-4b8e-416f-b5d3-63fc0ea7e775_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18332320","rdfs:label":"Family 2","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/8c3a3be8-4b8e-416f-b5d3-63fc0ea7e775","type":"Family","rdfs:label":"Family 2","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/5672828e-0b11-48bb-87ae-85aca81eaae2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18332320","rdfs:label":"III:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"detectionMethod":"The 38 exons and flanking exon-intron boundaries of the KIF21A gene were sequenced via PCR. Exons 8, 20, and 21, with reported mutations were sequenced in the proband. \n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Bilateral severe ptosis, compensatory head position with typical chin-up appearance, hypotropia with or without exotropia, and severely impaired vertical and horizontal\nocular motility\n","phenotypes":["obo:HP_0001488","obo:HP_0001477","obo:HP_0001491","obo:HP_0000006"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/034de6bb-2803-45f1-8806-f08020408dad_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18332320","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Bilateral severe ptosis, compensatory head position with typical chin-up appearance, hypotropia with or without exotropia, and severely impaired vertical and horizontal\nocular motility\n","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0000006","obo:HP_0001477","obo:HP_0001488","obo:HP_0001491"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/5672828e-0b11-48bb-87ae-85aca81eaae2"}},{"id":"https://genegraph.clinicalgenome.org/r/d129c6d8-b5e1-4719-8617-4f3726878586_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19551685","rdfs:label":"Family 3","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/d129c6d8-b5e1-4719-8617-4f3726878586","type":"Family","rdfs:label":"Family 3","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/3ee17f46-2327-4fdd-8b79-18c58068303a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19551685","rdfs:label":"I:2","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"detectionMethod":"DNA extracted form blood samples were used for genetic analysis via PCR. All 37 KIF21A exons  and corresponding exon-intron boundaries were amplified from genomic DNA. Haplotype analysis was also used to to genotype for genetic markers flanking the KIF21A gene. \n","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Eyes fixed in downgaze and exotropia or esotropia and severe limitation of elevation. Bilateral ptosis was present in all individuals in a variable degree","phenotypes":["obo:HP_0001488","obo:HP_0000006","obo:HP_0001491","obo:HP_0000577"],"previousTesting":false,"secondTestingMethod":"Other","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/59fb4186-133c-4ae0-b17b-76c3700af56b_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Eyes fixed in downgaze and exotropia or esotropia and severe limitation of elevation. Bilateral ptosis was present in all individuals in a variable degree","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001488","obo:HP_0000006","obo:HP_0000577","obo:HP_0001491"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/3ee17f46-2327-4fdd-8b79-18c58068303a"}},{"id":"https://genegraph.clinicalgenome.org/r/f8b8a165-8252-4f83-ae52-d30df2c787d2_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621876","rdfs:label":"Family S","family":{"id":"https://genegraph.clinicalgenome.org/r/f8b8a165-8252-4f83-ae52-d30df2c787d2","type":"Family","rdfs:label":"Family S","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/bed57a39-8300-4b6f-855e-9f466de8e52e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15621876","rdfs:label":"Proband 3","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7a2e9b-fafa-4c34-adc4-b06f76d0cc37"},"detectionMethod":"PCR was used to amplify the 38 KIF21A exons and flanking intronic sequence from genomic PCR amplification of DNA obtained from blood samples was used to analyze exons 20 and 21 in the KIF21A gene. DNA typing for linkage to the FEOM1 (12p11.2-q12) loci was performed on lymphocyte DNA using the polymorphic fluorescent microsatellite markers D12S1048 and D12S331.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Bilateral ptosis and infraducted eyes ","phenotypes":["obo:HP_0001488","obo:HP_0001491"],"previousTesting":false,"secondTestingMethod":"Linkage analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/04bb773f-0332-42ae-ac67-1f1f29dd1479_variant_evidence_item"}}},"phenotypeFreeText":"Bilateral ptosis and infraducted eyes ","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0001491","obo:HP_0001488"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/bed57a39-8300-4b6f-855e-9f466de8e52e"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/b8c58efb-9d6e-4b98-b2e4-64dc3be68d71","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b8c58efb-9d6e-4b98-b2e4-64dc3be68d71_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f677ad2e-26ea-44a4-8463-b59f0a4bbf06","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f677ad2e-26ea-44a4-8463-b59f0a4bbf06_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17511870","allele":{"id":"https://genegraph.clinicalgenome.org/r/9b951896-1984-4b61-82af-f83197d586d8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001173464.2(KIF21A):c.2830G>C (p.Glu944Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384393276"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/034de6bb-2803-45f1-8806-f08020408dad","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/034de6bb-2803-45f1-8806-f08020408dad_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/cc32bbc2-de76-42d0-8a6b-b3c3393ddd30_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc32bbc2-de76-42d0-8a6b-b3c3393ddd30_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eba1b071-3f64-4c79-9e47-935351d26cf0","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f9b0ffd-c4ba-4363-b828-6fcf64194c19","type":"Finding","dc:description":"Adult 129/S1Kif21aKImice exhibit the CFEOM1 external phenotype of unilateral or bilateral ptosis and/or globe retraction that is 92% penetrant and primarily homozygous inKif21aKI/KImice, 43% penetrant and primarily heterozygous inKif21a+IKImice, and absent inKif21a+/+ WT mice. Bilaterally affected adultKif21aKI/KImice showed a reduction in the number of OMN and abducens motor neurons and a reduction in the LPS muscle compared to WT. Kif21aKI/KImice recapitulated findings observed in humans with CFEOM1 with minimal differences\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24656932","rdfs:label":"KIf21A knock-in mouse ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/cc32bbc2-de76-42d0-8a6b-b3c3393ddd30_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/18c2eee0-c73c-4fc4-9957-c7e5c9130988","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7d2ee95-da9d-443e-829f-96fdec80bfcf","type":"Finding","dc:description":"we surveyed postmortem brain tissue from a 3.5 year old and a 65 year old, both of who died of non-neurological causes and did not have CFEOM.\n\n Similar to expression in mouse, we find human KIF21A to be expressed widely in neuronal cell bodies and their processes within both the central and peripheral nervous system, \nincluding all layers of the frontal and occipital cortex (Fig. 5A,B)\nhippocampus, striatum, and in the Purkinje cells of the cerebellum (Fig. 5C,D). \nMost neurons in the brainstem, including oculomotor(EF), trochlear (G,H), and abducens motor neurons (I,J), express KIF21A (Fig. 5EJ).\nThroughout all levels of the spinal cord, alpha-motor neurons and their processes were immunoreactive for KIF21A (Fig 5KL).\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22465342","rdfs:label":"KIF21A expression in EOM ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Definitive","sequence":3537,"specifiedBy":"GeneValidityCriteria8","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ZY7RKkQ81oA","type":"GeneValidityProposition","disease":"obo:MONDO_0007614","gene":"hgnc:19349","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_cc32bbc2-de76-42d0-8a6b-b3c3393ddd30-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}